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D
eﬁning the molecular mechanisms linking obe-
sity with insulin resistance is important for
developing new therapies against the rising
incidence of type 2 diabetes in industrialized
nations. Maintaining a balance between calorie intake and
energy expenditure is critical for preventing insulin resis-
tance, the precursor for type 2 diabetes (1). Mouse genet-
ics has made enormous contributions to theoretical
models explaining how organisms balance energy intake
and energy expenditure. A seminal event was the posi-
tional cloning of the obese gene (now called the Leptin
gene) by Friedman and colleagues in the early 1990s (2).
Leptin deﬁciency causes severe obesity in mice and hu-
mans (3), and leptin was proposed to regulate energy
homeostasis by suppressing appetite and increasing en-
ergy expenditure (4). However, it has clearly been forgot-
ten that the interpretation of energy expenditure data from
mice homozygous for the Lep
ob mutation was challenged
shortly after the initial publication (5). Increasingly sophis-
ticated technologies for manipulating the mouse genome
are now used routinely to analyze new genes linked to
energy homeostasis, resulting in many new mouse models
with obese or lean phenotypes. Altered energy expendi-
ture is frequently cited as the primary mechanism under-
lying the obese or lean phenotype. However, in many cases
the same issues with interpretation of energy expenditure
data are evident. Here, we discuss what has developed into
a recurring problem in the literature with the analysis of
energy balance. Speciﬁcally, we shall discuss the practice
of using body weight as a denominator in analyzing energy
balance to overestimate the role of energy expenditure.
The growing number of individuals with chronic meta-
bolic diseases like type 2 diabetes provides a powerful
incentive for investigating mechanisms linking obesity
with insulin resistance. That a balance between food
intake and energy expenditure (thermogenesis) is main-
tained through homeostatic mechanisms is a central tenet
of obesity research. A major goal is to discover mecha-
nisms to avoid a positive energy balance, a pathway to
weight gain, increased susceptibility to insulin resistance,
and diseases of the metabolic syndrome (6,7).
There has been signiﬁcant progress in understanding
how organisms regulate caloric intake and adiposity. Iden-
tiﬁcation of factors secreted from peripheral organs, in-
cluding leptin and adiponectin from adipocytes, insulin
from the pancreas, ghrelin from the stomach, and ﬁbro-
blast-growth factor-21 from the liver and examining how
they regulate adiposity and insulin sensitivity has been
essential for the evolving concepts of energy homeostasis
(8–10). These factors have been found to interact with
networks of speciﬁc neurons in the hypothalamus and
brain stem, modulating behaviors relevant to energy ho-
meostasis including satiety, reward, and motivation (11–
13). Through regulating autonomic and neuroendocrine
output, and by acting directly on peripheral tissues, these
factors can regulate glucose and lipid homeostasis. Impor-
tantly, aberrant regulation and action of these molecules
has been linked to the development of insulin resistance
and diabetes in the obese state. These ﬁndings have given
hope that therapies designed to restore or replace the
normal function of these peptides will provide effective
treatment for obesity and the associated metabolic
disorders.
Neuroendocrine factors that regulate food intake have
been reported to have reciprocal effects on thermogenesis
that should, in principle, facilitate attainment of energy
balance. A frequently cited example is the ability of leptin
to inhibit food intake and stimulate thermogenesis (4), the
latter occurring through stimulating the activity of uncou-
pling protein 1 (UCP1) in brown adipose tissue (BAT) (14).
The central nervous melanocortin system, primarily acting
through melanocortin-4 receptors (Mc4r), has also been
suggested to function similarly. Mc4r-deﬁcient mice do not
exhibit diet-induced thermogenesis (15) linked to impaired
regulation of BAT UCP1 expression (16). Collectively,
these and other observations form the basis of a neuro-
molecular model linking calorie intake and diet-induced
thermogenesis, a system for maintaining energy homeosta-
sis proposed by Rothwell and Stock nearly 30 years ago
(17).
While such a model linking food intake to thermogene-
sis is theoretically satisfying, it falls short for several
reasons. The clinical relevance is unclear, as it has long
been debated whether nonshivering thermogenesis is the
basis for diet-induced thermogenesis in humans (18).
However, recent reports on the presence of deposits of
brown adipocytes in adult humans (19–21), and the dis-
covery of molecular mechanism for transforming myo-
cytes into brown adipocytes (22), will likely further
stimulate this debate. Several studies have also failed to
demonstrate that leptin stimulates thermogenesis, as de-
termined by measuring oxygen consumption, even when
administered to Lep
ob/Lep
ob mice (23). That the marked
decline in leptin associated with food restriction instigates
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duction in energy expenditure is not disputed (24). Also
not disputed is the experimental evidence for systems
residing in the hypothalamus responding to hormones and
metabolites that, when disrupted, lead to rapid weight gain
and insulin resistance (25). However, the ability of leptin
per se to stimulate a compensatory thermogenic effect in
the well-fed state is negligible (23), while lean animals fail
to respond to pharmacological doses of leptin (4). A
positive energy balance is also rapidly associated with a
state of leptin resistance and deterioration in the hypotha-
lamic control of energy homeostasis (26).
Another key point is that we have little documented
knowledge for a thermogenic mechanism that has the
prevention of positive energy balance as its primary func-
tion. An alternative hypothesis is that the physical effort to
feed life and limb and escape predators precluded the
evolution of a thermogenic system to protect those few
with the luxury of having a positive energy balance (27).
However, complementation of this perceived evolutionary
deﬁciency in energy homeostasis through pharmacological
stimulation of thermogenesis remains an important goal
for developing drugs against obesity and diabetes.
Finally, recent data from studies investigating how
calorie restriction affects mitochondrial activity also ques-
tion our assumptions of a correlation between calorie
intake and thermogenesis. Calorie restriction extends
lifespan in rodents and is associated with reduced energy
expenditure. However, calorie restriction stimulates mito-
chondrial biogenesis in skeletal muscle, a response involv-
ing nuclear factors that regulate mitochondrial biogenesis,
such as Pgc1a (28). In other words, while a positive
correlation between calorie intake and physical energy
expenditure exists, it is not necessarily associated with
stimulating mitochondrial respiratory activity at a molec-
ular level.
A problem in the obesity research ﬁeld lays in the
interpretation of energy expenditure data. The fact
remains that an urgent need exists for the development of
new therapies to control body weight and improve insulin
action, and modulation of energy expenditure provides
one potential therapeutic target. The availability of spon-
taneous and targeted mutations in mice is an important
resource for identifying novel genes involved in energy
homeostasis. Hardly a month goes by without publication
of data demonstrating novel mechanisms for regulating
adipose mass or further characterizing pathways of previ-
ously identiﬁed genes involved in regulating satiety or
metabolism (Table 1). Often these mutant genes are re-
ported to affect obesity/leanness and diabetes phenotypes
as a consequence of their effects on substrate oxidation
and energy expenditure. However, few of these have
ultimately led to the identiﬁcation of the novel underlying
thermogenic mechanism.
The problem facing the ﬁeld is that, with the exception
of UCP1/BAT thermogenesis, there is little evidence for an
alternative thermogenic mechanism. A case has been
made for UCP1/BAT as a thermogenic mechanism for
diet-induced thermogenesis at thermoneutrality (29,30).
However, mice in research colonies and in the wild and
humans before World War II did not spend most of their
time at thermoneutrality, and the evidence is clear that at
even slightly reduced ambient temperatures (24°C) UCP1/
BAT is not required for diet-induced thermogenesis (31–
34). Even severely obese Lep
ob/Lep
ob mice, which exhibit
clear deﬁcits in BAT thermogenesis in response to cold
exposure, exhibit a robust increase in oxygen consump-
tion in response to hyperphagia (15,35). While it is clear
that mutations and environmental conditions that affect
UCP1/BAT will impact diet-induced obesity, these condi-
tions can affect fuel supply for BAT thermogenesis, for
example, acyl-CoA dehydrogenases knockouts (36), or can
inactivate transcription factors (37,38) or receptors (39,40)
associated with the cold-mediated induction of thermo-
genesis BAT. Although these mutations primarily affect the
efﬁciency of a thermogenic mechanism devoted to body
temperature regulation, the efﬁciency of UCP1/BAT ther-
mogenesis indirectly affects body weight regulation as less
efﬁcient systems for maintaining core body temperature
require more calories.
TABLE 1
Publications claiming an energy expenditure phenotype based
upon erroneous estimates of oxygen consumption
Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny
JM, Moghal N, Lubkin M, Kim YB, Sharpe AH,
Stricker-Krongrad A, Shulman GI, Neel BG, Kahn BB.
Increased energy expenditure, decreased adiposity, and
tissue-speciﬁc insulin sensitivity in protein-tyrosine
phosphatase 1B-deﬁcient mice. Mol Cell Biol
2000;20:5479–5489
Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker
M, Fumagalli S, Allegrini PR, Kozma SC, Auwerx J, Thomas
G. Absence of S6K1 protects against age- and diet-induced
obesity while enhancing insulin sensitivity. Nature
2004;431:200–205
Jiang G, Li Z, Liu F, Ellsworth K, Dallas-Yang Q, Wu M, Ronan
J, Esau C, Murphy C, Szalkowski D, Bergeron R, Doebber T,
Zhang BB. Prevention of obesity in mice by antisense
oligonucleotide inhibitors of stearoyl-CoA desaturase-1.
J Clin Invest 2005;115:1030–1038
Picard F, Géhin M, Annicotte J, Rocchi S, Champy MF,
O’Malley BW, Chambon P, Auwerx J. SRC-1 and TIF2
control energy balance between white and brown adipose
tissues. Cell 2002;111:931–941
Smith SJ, Cases S, Jensen DR, Chen HC, Sande E, Tow B,
Sanan DA, Raber J, Eckel RH, Farese RV Jr. Obesity
resistance and multiple mechanisms of triglyceride synthesis
in mice lacking Dgat. Nat Genet 2000;25:87–90
Tansey JT, Sztalryd C, Gruia-Gray J, Roush DL, Zee JV,
Gavrilova O, Reitman ML, Deng CX, Li C, Kimmel AR,
Londos C. Perilipin ablation results in a lean mouse with
aberrant adipocyte lipolysis, enhanced leptin production, and
resistance to diet-induced obesity. Proc Natl Acad SciUSA
2001;98:6494–6499
Hofmann SM, Zhou L, Perez-Tilve D, Greer T, Grant E,
Wancata L, Thomas A, Pﬂuger PT, Basford JE, Gilham D,
Herz J, Tschöp MH, Hui DY. Adipocyte LDL receptor-related
protein-1 expression modulates postprandial lipid transport
and glucose homeostasis in mice. J Clin Invest
2007;117:3271–3282
Almind K, Kahn CR. Genetic determinants of energy
expenditure and insulin resistance in diet-induced obesity in
mice. Diabetes 2004;53:3274–3285
Martinez-Botas J, Anderson JB, Tessier D, Lapillone A, Chang
BH-J, Quast MJ, Gorenstein D, Chen K-H, Chan L. Absence
of perilipin results in leanness and reverses obesity in
Lepr
db/db mice. Nature Genetics 2000;26:474–479
Plum L, Rother E, Munzberg H, Wunderlich FT, Morgan DA,
Hampel B, Shanabrough M, Janoschek R, Konner AC, Alber
J, et al. Enhanced leptin-stimulated PI3k activation in the
CNS promotes white adipose tissue transdifferentiation. Cell
Metab 2007;6:431–445
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have not been found does not mean that ion/substrate
cycles could not serve this function (41–45). Presumably
some targeted mutations with adiposity phenotypes are
based upon UCP1-independent alternative thermogenic
mechanisms. However, inspection of the phenotypic data
for energy expenditure in the studies cited in Table 1
readily leads one to the disappointing conclusion that it is
probable that none of them have a bona ﬁdes defect in
energy expenditure.
What is the basis for this provocative statement? It will
be obvious to anyone that has used indirect calorimetry
for comparing lean and obese mice that total 24-h energy
expenditure (TEE) increases as a function of body weight.
Studies comparing 24-h energy expenditure in humans
with a wide range of body weight also demonstrate an
increase in 24-h energy expenditure (46). To compensate
for the often dramatic differences of body mass in lean and
obese models, and perhaps to estimate energy expenditure
at a cellular level, investigators have resorted to normal-
izing energy expenditure reported as oxygen consumption
(VO2) to body weight. This approach assumes that lean and
adipose tissues contribute equally to VO2; however, while
adipose tissue is not metabolically inert, it contributes
relatively little to the total energy expenditure of an
organism compared with lean mass. Furthermore, this
distortion in estimates of energy expenditure will increase
in proportion to the accumulation of lipid in the adipocyte
as obesity increases.
The theoretical and experimental bases for the effect of
mass on energy expenditure are complex and have been
covered in depth by many physiologists for over a century.
A particularly lucid account can be found in “Energy
Metabolism in Animals and Man” by Kenneth Blaxter (NY,
Cambridge University Press, 1989). During the past 7
years, in excess of 10 papers published in high proﬁle
journals devoted to the phenotypic characterization of
new targeted gene mutations affecting body composition
have calculated whole-body energy expenditure by divid-
ing the volume of oxygen consumed by the total body
weight (Table 1). This use of body weight to normalize
energy expenditure data between groups of mice with
often marked differences in body weight makes the as-
sumption that all tissues have an equivalent metabolic
demand. A variation in estimating energy expenditure to
account for differences in the mass of mutant versus
wild-type mice divides oxygen consumption by body
weight to the 3/4 power. It has long fascinated biologists
that body mass and energy expenditure among a range of
species vary as a function of the 3/4 power (47,48).
However, it is assumed that species that conform to this
relationship will have normal body composition, that is,
neither obesity nor insulin resistance. Therefore, including
a highly variable fat mass in the body weight when the lean
mass is minimally variable will similarly distort estimates
of energy expenditure.
As an example, we provide data from our studies
analyzing energy expenditure in genetic mutants that
exhibit obesity owing to increased fat mass (Fig. 1A).
Obesity associated with mutations in either the leptin or
melanocortin-4 receptor (Mc4r) genes is associated with a
30–40% increase in TEE expressed as kilojoules per
mouse per day (Fig. 1B) (49,50). Normalization of TEE by
body weight (which includes substantial increases in the
amount of adipose in the obese models, Fig. 1A) appears
to indicate lower TEE per unit of body weight with
extreme obesity, at least in females. Two-way ANOVA
indicates signiﬁcant effects of genotype (P  0.0001) and
sex (P  0.0001), with the effect of genotype dependent on
sex (P  0.05). TEE per gram of body weight was
signiﬁcantly lower in female Lep
ob/Lep
ob mice compared
with wild type (P  0.0001).
When the same data are normalized using lean mass, a
very different outcome is observed. TEE per gram of lean
mass is signiﬁcantly (and markedly) increased with obe-
sity (effect of genotype, P  0.0001, P  0.002 between all
genotypes). Sex also signiﬁcantly affected TEE per gram of
lean mass, with males having a lower value irrespective of
genotype (P  0.0001); however, sex had no affect on the
impact of genotype. Note that the quite large differences of
fat mass observed between Mc4r
/ and Lep
ob/Lep
ob mice
(10 g, or 15–20% of total body weight) do not correlate
with signiﬁcant changes in TEE (Fig. 1B). This suggests
that the additional fat mass is not associated with any
appreciable increase of metabolic activity.
One interpretation of this data is that severe obesity is
supported by increased energy expenditure. As both ge-
netic models of obesity may be hyperphagic relative to
lean controls, the oxidation of any additional calories
could contribute to increased energy expenditure. Note
that while these genetic mutants obviously accumulate
more mass over several weeks to a few months, these
recordings were taken over a time frame of a few days
where minimal or no signiﬁcant change in body mass
would occur. In other words, the state of energy balance
(intake less expenditure) is likely near neutrality, and any
additional calories ingested are likely being oxidized or
used to support the maintenance of the additional mass
(i.e., oxygenation and turnover of protein and lipid in the
extra tissue). Similar results were observed whether the
analysis used total energy expenditure or resting energy
expenditure, assessed using data obtained during period
of minimal activity.
The rationale for dividing VO2 by body weight to calcu-
late energy expenditure is also sometimes applied to food
intake. That is, food intake is expressed as gram or calorie
per gram of body weight. Of course, when applied univer-
sally the outcome makes no sense, since it would result in
the conclusion that leptin-deﬁcient Lep
ob/Lep
ob mice are
hypophagic. In some instances authors will present one
parameter adjusted for body weight and one expressed per
animal (or per lean mass). Quite often, the presentation of
data appears to reﬂect a desire to align the data with
assumptions made a priori, as opposed to an unbiased
analysis of the contribution of food intake or energy
metabolism to the phenotype being investigated.
To illustrate the problem we draw attention to two
recent examples, one a report by Plum et al. in Cell
Metabolism (51), and the other by Hofmann et al. in the
Journal of Clinical Investigation (52). Plum et al. per-
formed a technological tour-de-force by deleting the
phosphatidylinositol-3-phosphate (PIP3) kinase Pten, spe-
ciﬁcally neurons expressing the long-form of the leptin-
receptor (ObRb). The deletion of Pten in ObRb neurons
(Pten
ObRB) resulted in the over activation of the phospha-
tidylinositol-3 (PI3) kinase pathway, previously reported
to be involved in the anorectic actions of leptin (53). As
predicted, these mice exhibit a lean phenotype, with a
marked reduction in perigonadal fat pad weight and a
10–15% (2- to 3-g) reduction in body weight. The lean
phenotype was largely attributed to energy expenditure,
based upon increased VO2 expressed as milliliters per
A.A. BUTLER AND L.P. KOZAK
diabetes.diabetesjournals.org DIABETES, VOL. 59, FEBRUARY 2010 325kilogram per hour; however, this increase in energy ex-
penditure would disappear if expressed as VO2 in milliliters
per mouse per hour or milliliters per gram of lean mass per
hour. Additionally, the authors confound the problem by
presenting food intake accumulated over 3 weeks by
adjusting to body weight (grams per grams per day). Based
on the body weight data, it appears likely that there would
be mild reduction in total food intake in Pten
ObRB mice
compared with controls, which could contribute to the
lean phenotype. More surprisingly, in the same ﬁgure, food
intake during a 6-h period after an overnight fast was
expressed as gram per animal and was not different. No
rationale is provided for the ad hoc adjustment of food
intake for body weight. Their conclusion is that Pten
ablation in leptin-sensitive neurons reduces adiposity by
increasing energy expenditure.
The Hofmann et al. article is another molecular genetic
tour-de-force in which adipocyte LDL receptor–related
protein-1 was speciﬁcally inactivated in white adipose
tissue to assess its role in diet-induced obesity. However,
the authors use the same problematic experimental ap-
proach to calculate energy expenditure from indirect
calorimetry, food intake, and, in addition, loss of fat mass
during fasting, and they come to a similar conclusion,
namely that reduced adiposity is caused by elevated
energy expenditure from enhanced muscle thermogenesis.
In both studies if the energy expenditure was calculated
by normalizing to lean body mass or total energy expen-
diture per mouse, then no signiﬁcant differences would
have been observed. It is important to emphasize that
these and other studies in Table 1 represent only a few of
many articles published in a broad spectrum of journals
that publish such research.
The complex issues faced when characterizing energy
expenditure. This issue with the analysis of indirect
calorimetry data was raised in a letter in Science in 1997 by
Himms-Hagen (5). This letter was a response to the
publication of the ﬁrst studies on the effectiveness of
recombinant leptin to correct the obese phenotype of
Lep
ob/Lep
ob mice (4). The authors of that study claimed
that leptin increased energy expenditure in these mice
when calculating energy expenditure by dividing oxygen
consumption by body weight. Himms-Hagen pointed out
that if energy expenditure is estimated from oxygen con-
sumption per mouse, it leads to the conclusion that leptin
stimulates fat oxidation and reduces food intake in the
Lep
ob/Lep
ob mouse, but it does not stimulate energy expen-
diture. The serious negative consequence of the conclu-
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FIG. 1. Comparison of energy expenditure in genetically obese mouse strains using data expressed per mouse or adjusted for body weight (BW)
or fat-free mass (FFM). The data shown are from studies performed by the Pennington Biomedical Research Center using indirect calorimetry
(Columbus Instruments). The numbers in parentheses in A indicate the number of animals used per genotype. Data were analyzed by two-way
ANOVA, testing for signiﬁcance of sex, genotype, and interactions. A: Body composition (fat-free mass) of male and female wild-type (WT),
Mc4r
/ (Mc4r), and Lep
ob/Lep
ob (Ob) mutant mice on the C57BL/6J background was measured using nuclear magnetic resonance (Bruker
Minispec) (61). The effects of genotype were highly signiﬁcant (*P < 0.0001 between all groups); sex did not alter the effect of genotype on
obesity. Fat-free mass was affected by genotype (P < 0.0001) and sex (P < 0.0001), with Mc4r
/ mice having signiﬁcantly more fat-free mass than
wild-type and Lep
ob/Lep
ob mice (#P < 0.01), while male mice had greater fat-free mass irrespective of genotype. , fat mass; p, fat-free mass. B:
When expressed per animal, TEE was increased by obesity (effect of genotype, *P < 0.0001 vs. wild type; effect of sex, P  0.27). C: Normalization
of TEE by body weight or lean mass yielding different results. TEE expressed per gram of fat-free mass is signiﬁcantly increased relative to
control mice. f, wild-type B6; o, B6. Mc4r
/; , B6. Lep
ob/Lep
ob.
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ob/Lep
ob mice have a slow metabolism led to
years of fruitless and expensive clinical studies on obese
humans seeking to ﬁnd obese individuals with a slow
metabolism. None were found, and the blame for these
fruitless studies was placed on the Lep
ob/Lep
ob mouse,
claiming that its obesity is not similar to human obesity
(54). However, a review of energy expenditure data in the
Lep
ob/Lep
ob, Mc4r
/, and wild-type mice from our labo-
ratories illustrates how Lep
ob/Lep
ob have a slow metabo-
lism when oxygen consumption data are expressed per
gram of body weight (Fig. 1) but not when oxygen
consumption data are expressed per gram of lean mass or
per mouse. Thus, the problem is not with the mouse model
but with the inability to appreciate that a unit of fat mass
has a lower level of oxygen consumption than a unit of
lean mass.
The letter by Himms-Hagen should have signiﬁcantly
reduced the publication of studies that employed similar
methods; however, the extensive list of high-proﬁle publi-
cations since 1997 in which changes in adiposity have been
erroneously attributed to modulations in energy expendi-
ture indicates that the problem continues (Table 1). Con-
sequently, these conclusions as to how various metabolic
pathways contribute to obesity phenotypes through mod-
ulation of energy expenditure impair progress in this area.
The effect of genetic manipulation on the basic adiposity
phenotype is not in dispute, rather the manner in which
indirect calorimetry has been used to provide a physiolog-
ical mechanism based upon energy expenditure is the
problem.
This point is further illustrated using a simple thought
experiment showing that subtle differences in energy
expenditure can account for marked differences in the
accumulation of adipose over time. A difference of 0.5
g/week in the rate of accumulation of fat between a mutant
and control mouse would, if constant, result in a 10-g
difference in body weight over 5 months. These estimates
are not unreasonable, as studies examining obesity phe-
notype usually involve mice in the 4- to 6-month age range
(if not older); a difference of 10 g represents a marked
change for the B6 mouse, which weighs 25–30 g when
maintained on standard chow, increasing to 45–50 g when
fed a high-fat diet. However, this number represents a
difference of 18.8 kJ per week, or 2.9 kJ/day. Assuming a
range of energy expenditure of 50–60 kJ/day and identical
caloric intake, then this would mean a difference in daily
energy expenditure of 5%, which is at the limits of the
discriminatory capacity of indirect calorimetry.
Of course, this crude estimation does not take into
account the actual efﬁciency of the conversion of nutrients
to triglyceride stores in adipose. It also does not take into
account differences in the balancing of nutrient composi-
tion with substrate oxidation, indicated by the respiratory
exchange ratio, which may also impact energy homeosta-
sis. However, it does highlight the small changes in energy
balance that can explain relatively large differences in the
accumulation of adipose mass over time. Similar reason-
ing has been applied to the normally exquisite regulation
of energy balance affecting adiposity over time in humans
(55).
The number of studies where energy expenditure has
been expressed as VO2 divided by total body weight
appears not to have been diminished by Himms-Hagen’s
admonitions. In most cases articles identifying a speciﬁc
thermogenic mechanism associated with the phenotypes
have not followed these initial reports. In other cases,
modest changes in Ucp1 mRNA expression especially in
white adipose tissues have been interpreted to implicate
alterations in UCP1 as the thermogenic mechanism under-
lying the differences in energy expenditure (51,56). How-
ever, whether a 50% change in Ucp1 expression affects
overall adiposity is questionable given that complete deﬁ-
ciency of UCP1 does not affect the obese state or energy
expenditure at an ambient temperature of 23°C (34). Cold
tolerance has also been used by many studies as an ad hoc
indicator of reduced metabolism; however, even this in-
terpretation is complicated, since homozygous Lep and
Ucp1 mutant mice can, given the right conditions or, in the
case of UCP1-deﬁcient mice on an F1-hybrid background,
adapt to cold (57).
Some recommendations. We have approached this dis-
cussion of the problems arising from calculations of
energy expenditure from VO2 data based upon an oversim-
pliﬁed obesity model in which the only morphological
variable is body fat content. Mutations in pleiotropic
signaling molecules may not only affect body fat content,
but also change the overall size and body composition and
affect behavioral phenotypes changing physical activity
and food intake. Two recent studies on the targeted
inactivations of the FTO and IKK[epsilon] genes have the
potential of having a high impact on studies of human
obesity, especially FTO, given the association of FTO
alleles with human obesity. These studies also propose
that differences in diet-induced obesity are due to differ-
ences in energy expenditure (58,59); however, this inter-
pretation is uncertain because of signiﬁcant differences in
both lean and fat mass in the mutant versus wild-type
mice. Each of these subphenotypes will have an effect on
calculations of energy expenditure. Therefore, data pro-
vided by systems for assessing energy expenditure require
evaluation with respect to each of the morphological and
the behavioral variables. If a change in adiposity is deter-
mined by mutations to enzymes of fat metabolism or to
preferential fat oxidation, then the respiratory quotient
can provide additional useful information. In addition, an
independent evaluation of energy expenditure can readily
be acquired by determination of metabolic efﬁciency, that
is, by measuring changes in adiposity and lean mass
relative to caloric intake over the course of several weeks
or months.
Finally, regression analysis of energy expenditure against
body composition data, which is the method of choice in
determining energy expenditure in humans (46), could be
used. However, this approach is impractical for mouse
studies characterizing the effects of targeted mutations on
obesity and energy expenditure. In most laboratories, rela-
tively small numbers (6–10) of age- and sex-matched mutant
and wild-type mice are available for indirect calorimetry
studies. However, if variation in lean mass or body size was
present as revealed by duel-energy X-ray absorptiometry or
nuclear magnetic resonance, then analysis by regression
analysis would be justiﬁed. Alternatively, National Institutes
of Health (NIH)-funded investigators in institutions without
the technology for indirect calorimetry or analysis or body
composition by nuclear magnetic resonance can send ani-
mals to the NIH-funded Mouse Metabolic Phenotyping Cen-
ters (http://www.mmpc.org/).
Final remarks. We have attempted to refocus attention
on a signiﬁcant but easily corrected problem encountered
often in the literature in studies determining energy ex-
penditure in animals with variations in adiposity, and ﬁrst
clearly enunciated by Jean Himms-Hagen 12 years ago (5).
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ergy balance is a challenging endeavor inﬂuenced by
variations in physical activity, circadian rhythms, subtle
differences of substrate utilization, and diet composition.
Careful phenotyping can provide unique insights into
energy balance at the whole animal level that cannot be
obtained through molecular or cell culture experiments.
However, major problems lie ahead as our ability to
generate new knockout models has outstripped our capac-
ity for a thorough investigation of phenotype. The techni-
cal feasibility of rapidly generating knockout gene models
has led to an international consortium to knockout every
gene in the mouse (http://www.genome.gov/17515708).
However, we are not the ﬁrst to voice concern about
whether the experience, resources, and ﬁnancing are
available ﬁrst to design physiologically meaningful gene
knockouts of energy balance and second to create and
support the laboratories with the experience to phenotype
the mice for defects in energy homeostasis (60).
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